Another "bad" Cholesterol Discovered: "bad News" for Heart Disease

Another 'bad' type of cholesterol that contributes to heart disease has been discovered by scientists at Oxford University.

Lipoprotein(a) or Lp(a) cannot be controlled by cutting down on dietary fats or taking a statin drug, unlike the well-known LDL cholesterol.

Bad Cholesterol Controlled by "Idol" Enzyme
An enzyme that controls the so-called bad cholesterol , which is often linked with heart disease and clogged arteries has been identified

However, researchers say high levels do not carry the same risk as LDL and other drugs might work to minimise its effects.

LDL is considered the aggressive tiger of the cholesterol world, furring the arteries and greatly increasing heart risk.

The research into Lp(a) found that levels of cholesterol appear to depend on our genes.

Statin Therapy Cuts Bad Cholesterol Unprecedented 70 Percent
Research conducted at the Methodist DeBakey Heart Center in Houston shows that a combination statin therapy lowers bad cholesterol by an unprecedented 70 percent

Study's lead author Professor Martin Farrall and colleagues used gene-chip technology to scan DNA that they knew from previous studies were potential "hotspots" for heart disease risk. This analysis revealed the two genetic culprits.

Farrall said one in six people carries one or more of the genes for Lp(a)."The increase in risk to people from high Lp(a) levels is significantly less severe than the risk from high LDL cholesterol levels," the BBC quoted him as saying.

Bad Cholesterol Inhibits Breakdown of Fat in Cells
A study has revealed that the so-called bad cholesterol (LDL) inhibits the breakdown of fat in cells of peripheral deposits.

"So Lp(a) doesn't trump LDL, which has a larger impact and which we can already control pretty effectively.

"The hope now is that by targeting both we could get even better risk reduction," he added.

Designer RNA Reduces Bad Cholesterol by Two-thirds
According to a group of researchers, small, specially designed bits of ribonucleic acid (RNA) can interfere with cholesterol metabolism, reducing harmful cholesterol by two-thirds

The study has been published in the New England Journal of Medicine.

Source-ANI
TRI/L